Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial.

Date publication

janvier 2017

Journal

Cancer chemotherapy and pharmacology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry

Tous les auteurs :
Ducreux M, Bennouna J, Adenis A, Conroy T, Lièvre A, Portales F, Jeanes J, Li L, Romano A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27866244

Résumé

This single-arm, phase II trial evaluated nab-paclitaxel monotherapy in pretreated patients with metastatic colorectal cancer (mCRC).

Mots clés

Colorectal cancer, Metastatic, Previously treated, Refractory, nab-Paclitaxel

Référence

Cancer Chemother. Pharmacol.. 2017 Jan;79(1):9-16